Colorectal Cancer in Crohn's Disease
- Conditions
- Colorectal CancerInflammatory Bowel DiseasesCrohn Disease
- Interventions
- Procedure: Total proctocolectomyProcedure: Total colectomyProcedure: Segmental colectomy
- Registration Number
- NCT04654494
- Lead Sponsor
- University of Rome Tor Vergata
- Brief Summary
Retrospective multicentre study. All patients with a diagnosis of Crohn's disease (CD) and operated for colorectal cancer (CRC) between 01/01/2010 and 01/01/2020 will be included in the dataset.
Data will include preoperative, intraoperative and postoperative variables, with long term follow up when feasible.
The study will focus on a comparison between patients treated with total proctocolectomy (TPC) and patients treated with subtotal colectomy (STC) or segmental resection (SR).
Primary endpoints will be oncologic outcomes, postoperative morbidity and mortality. Secondary endpoints include quality of life (QoL).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 70
- All patients with a diagnosis of Crohn's disease and concomitant primary colorectal cancer who underwent surgery in an expert centre between 01/01/2010 and 01/01/2020
- Patients who underwent non-oncologic segmental resection will be excluded from outcome analysis.
- Patients with known genetic colorectal cancer syndromes (eg. Familial Adenomatous Polyposis, Hereditary Non-Polyposis ColoRectal Cancer Syndrome)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chron's disease patients with colorectal cancer Total proctocolectomy This group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically Chron's disease patients with colorectal cancer Total colectomy This group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically Chron's disease patients with colorectal cancer Segmental colectomy This group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically
- Primary Outcome Measures
Name Time Method Overall Survival 5 years percentage of patients alive
disease free survival 5 years percentage of patients disease free
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Policlinico Tor Vergata
🇮🇹Roma, RM, Italy